<DOC>
	<DOCNO>NCT00858663</DOCNO>
	<brief_summary>The purpose study determine best dos RAD001 ( everolimus ) tablets cisplatin give patient receive radiation therapy head neck cancer .</brief_summary>
	<brief_title>Radiation Therapy ( IMRT ) + RAD001 ( Everolimus ) + Cisplatin Patients With Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Pathologically confirm head neck carcinoma , histology ( sarcoma , lymphoma , melanoma ) . Patients thyroid cancer ( papillary , follicular , undifferentiated , Hurthle cell , medullary , anaplastic ) may eligible . Patients cutaneous squamous cell cancer basal cell cancer arise head neck may eligible . Patients either Stage III IVB unresected disease ( Patients stage IIIV B hypopharynx cancer patient Stage IIB IVB nasopharynx cancer may also eligible ) OR Will status post macroscopically complete resection disease one follow poor risk feature surgical pathology specimen : Malignant involvement 2 regional lymph node Extracapsular extension nodal disease Microscopically involve mucosal margin resection T3 T4 pathologic stage ( exclude T3N0 laryngeal squamous cell cancer ) Perineural involvement Oral cavity oropharyngeal primary nodal disease level IV V Age &gt; = 18 year Karnofsky performance status &gt; = 70 % Adequate bone marrow function : Absolute neutrophil count &gt; = 1.5 X 109/L , Platelets &gt; = 100 x 109/L , Hemoglobin &gt; 10 g/dL . Adequate liver function : serum bilirubin &lt; = 1.5 X upper limit normal ( ULN ) , serum transaminase ( alanine aminotransferase , ALT ; aspartate aminotransferase , AST ) activity &lt; = 2.0 X ULN . Adequate renal function : serum creatinine within institutional normal limit , calculate creatinine clearance ( Cockcroft Gault method ) &gt; = 45 mL/min patient creatinine limit institutional normal . INR &lt; 1.5 aPTT &lt; 1.5 X upper limit normal For woman childbearing potential , negative urine serum pregnancy test within 14 day prior administration RAD001 . Men woman childbearing potential must willing consent use effective birth control method treatment least 3 month . The planned radiation therapy treatment dose must meet protocol requirement ( Resected tumors/postoperative patient : maximum plan dose 66 Gy . Unresected tumor : maximum plan dose 70 Gy ) . Any prior radiation therapy head neck cancer . Any prior radiation therapy &gt; 25 % bone marrow . Any prior radiation whole pelvis and/or brain . Patients unresected squamous cell cancer ( SCC ) arise oral cavity , oropharynx , larynx , hypopharynx exclude , unless receive least 2 cycle induction chemotherapy regimen include cisplatin carboplatin . ( For patient unresected head neck tumor SCC oral cavity , oropharynx , larynx , hypopharynx , requirement induction chemotherapy prior protocol chemoradiation ) .. Therapeutic anticoagulation coumadin ( warfarin ) Peripheral neuropathy &gt; = grade 3 , accord Common Terminology Criteria Adverse Events ( CTCAE ) , version 3.0 . Hypertriglyceridemia &gt; = grade 2 ( CTCAE version 3.0 ) . Patients require chronic treatment steroid ( &gt; prednisone 5 mg/day ) immunosuppressive agent exclude . Both cisplatin RAD001 immunosuppressive , chronic steroid use ( &gt; prednisone 5 mg/day ) use immunosuppressive agent might increase risk lethal infection set . Patients low dose steroid replacement regimen ( &lt; = prednisone 5 mg/day ) exclude , low dose steroid immunosuppressive . Impairment gastrointestinal function gastrointestinal disease may significantly alter absorption RAD001 ( e.g. , ulcerative disease , uncontrolled nausea , vomit , diarrhea , malabsorption syndrome small bowel resection ) . Active infection serious underlie medical condition would impair patient 's ability receive protocol treatment . Other concurrent severe and/or uncontrolled medical disease would compromise participation study opinion investigator ( e.g. , uncontrolled diabetes , unstable angina , congestive heart failure New York Heart Association Class III IV ) HIVpositive patient . These patient increase risk lethal infection treat marrow suppressive therapy . Additionally , pharmacokinetic interaction antiretroviral therapy study regimen may problematic patient . Women pregnant lactate Other active malignancy , indolent malignancy investigator determines unlikely interfere treatment safety analysis . For example , patient nonmelanoma skin cancer , situ carcinoma cervix , prostate cancer current biochemical ( PSA ) radiologic evidence disease may enroll . Impaired lung function : O2 saturation 88 % less rest room air Pulse Oximetry . If O2 saturation &lt; = 88 % rest , pulmonary function test ( PFTs ) order confirm normal pulmonary function eligibility . Patients receive immunization attenuate live vaccine within one week study entry study period . Close contact receive attenuated live vaccine avoid treatment everolimus . Examples live vaccine include intranasal influenza , measles , mumps , rubella , oral polio , BCG , yellow fever , varicella , TY21a typhoid vaccine . Liver disease cirrhosis severe hepatic impairment ( ChildsPugh class C ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>RAD001 ( Everolimus )</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>08-138</keyword>
</DOC>